Department of Gastroenterological Surgery and Transplantation CTx, Rigshospitalet, Copenhagen, Denmark.
Department of HPB Surgery, Imperial College, Hammersmith Hospital, London, UK.
Langenbecks Arch Surg. 2023 Aug 15;408(1):310. doi: 10.1007/s00423-023-03054-5.
Tumors with involvement of common hepatic and gastroduodenal arteries (CHA and GDA) or GDA and the proper hepatic artery (PHA) are traditionally considered nonresectable. We have devised a new procedure that includes pancreaticoduodenectomy with preoperative hepatic artery embolization (PD-HAE) to facilitate an R0 resection of tumors involving the hepatic arteries without vascular anastomoses and complete sacrifice of normal hepatic arterial blood supply.
To allow resection of the hepatic arteries, preoperative embolization of the PHA was performed to induce an increased collateral arterial blood flow from the periphery of the liver, far from the hepatic hilum 10-14 days prior to the operation. Between May 1, 2017 and December 31, 2019, eight patients with ductal adenocarcinoma were operated with the PD-HAE procedure.
The embolizations were uneventful apart from a transient marginal elevation of alanine aminotransferase in three patients. All patients had N disease with perineural invasion of tumor cells around the adventitia of the artery and severe perivascular inflammation. An R0 resection (> 1.0 mm to all resection margins) was obtained in six patients (75%). Mean hospital stay was 12 days. Median survival was 23 months (95% CI: 19.5-26.5 months). Six patients (75%) are still alive 11 to 36 months after the operation. There was perioperative fatality, and morbidity was comparable to standard pancreaticoduodenectomy.
PD-HAE is a safe procedure and may provide the opportunity for curative resection in otherwise unresectable patients. However, larger studies are needed to evaluate this procedure.
传统上认为累及肝总动脉和胃十二指肠动脉(CHA 和 GDA)或 GDA 和肝固有动脉(PHA)的肿瘤不可切除。我们设计了一种新的手术方法,包括术前肝动脉栓塞的胰十二指肠切除术(PD-HAE),以促进涉及肝动脉的肿瘤的 R0 切除,而无需血管吻合和完全牺牲正常肝动脉血供。
为了允许切除肝动脉,在手术前 10-14 天进行 PHA 栓塞,以诱导来自肝脏外周的增加的侧支动脉血流,远离肝门。2017 年 5 月 1 日至 2019 年 12 月 31 日,对 8 例导管腺癌患者进行了 PD-HAE 手术。
除了 3 例患者丙氨酸氨基转移酶短暂边缘升高外,栓塞均无并发症。所有患者均有 N 期疾病,肿瘤细胞沿动脉外膜神经周围侵犯,血管周围炎症严重。6 例患者(75%)获得了 R0 切除(>1.0 毫米至所有切缘)。平均住院时间为 12 天。中位生存期为 23 个月(95%CI:19.5-26.5 个月)。术后 11-36 个月,6 例患者(75%)仍存活。围手术期无死亡,发病率与标准胰十二指肠切除术相当。
PD-HAE 是一种安全的手术方法,可为原本不可切除的患者提供治愈性切除的机会。然而,需要更大的研究来评估该手术。